Hongzhou Cai

发表

Association of erythropoietin gene rs576236 polymorphism and risk of adrenal tumors in a Chinese population

C. Qin, Q. Cao, X. Ju, 2014, Journal of biomedical research.

One-Carbon Metabolism Pathway Gene Variants and Risk of Clear Cell Renal Cell Carcinoma in a Chinese Population

P. Shao, Pu Li, C. Qin, 2013, PloS one.

Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study

J. Li, P. Shao, Pu Li, 2013, BMC Cancer.

Classifying subtypes and predicting survival of renal cell carcinoma using histopathology image-based deep learning

Lian‐Wen Qi, Y. Geng, Xiangshan Fan, 2021 .

Association of N-acetyltransferase 1 Polymorphism and Bladder Cancer Risk: An Updated Meta-analysis and Trial Sequential Analysis

Z. Qin, Zicheng Xu, Xiao Li, 2017, The International journal of biological markers.

Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review

Zicheng Xu, Xiao Li, H. Cai, 2016, Clinical Cancer Research.

Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer

Jiajin Wu, Hongcheng Lu, H. Cai, 2022, Frontiers in Immunology.

Comprehensive FGFR3 alteration-related transcriptomic characterization is involved in immune infiltration and correlated with prognosis and immunotherapy response of bladder cancer

Weizhang Xu, Zicheng Xu, Yuxiao Zheng, 2022, Frontiers in Immunology.

Exosomal MicroRNA-9-3p Secreted from BMSCs Downregulates ESM1 to Suppress the Development of Bladder Cancer

Weizhang Xu, Zicheng Xu, Xiao Li, 2019, Molecular therapy. Nucleic acids.

Immunotherapy: Review of the Existing Evidence and Challenges in Breast Cancer

Yun Hu, Fenglin Huang, H. Cai, 2023, Cancers.

miR-154 inhibits prostate cancer cell proliferation by targeting CCND2.

Chao Qin, Jie Li, Pengfei Shao, 2014, Urologic oncology.

From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era

Tingting Feng, Xiaolan Lu, H. Cai, 2023, Biomedicine & Pharmacotherapy.

Comparison between transrectal and transperineal prostate biopsy for detection of prostate cancer: a meta-analysis and trial sequential analysis

Z. Qin, Weizhang Xu, Chuanjie Zhang, 2017, Oncotarget.

Editorial: Adaptive immune resistance in cancer therapy

Aimin Jiang, Linhui Wang, Zhigang Liu, 2023, Frontiers in Pharmacology.

Extracellular RNA in melanoma: Advances, challenges, and opportunities

Yang Cao, T. Zan, Zhouxiao Li, 2023, Frontiers in Cell and Developmental Biology.

Genetic Polymorphisms in IGF-I and IGFBP-3 Are Associated with Prostate Cancer in the Chinese Population

P. Shao, Pu Li, C. Qin, 2014, PloS one.

The relationship between functional promoter -94 ins/del ATTG polymorphism in NF-κ B1 gene and the risk of urinary cancer.

Pu Li, C. Yin, Weizhang Xu, 2016, Cancer biomarkers : section A of Disease markers.

Association between Manganese Superoxide Dismutase (MnSOD) Polymorphism and Prostate Cancer Susceptibility: A Meta-Analysis

J. Li, Kang Liu, Xiao Li, 2016, The International journal of biological markers.

The association between let-7 microRNA-binding site polymorphism rs712 and cancer risk: a meta-analysis and trial sequential analysis

Z. Qin, Weizhang Xu, Chuanjie Zhang, 2017 .

Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta‐analysis of 11 cohort studies

Bin Yu, Zicheng Xu, H. Cai, 2015, Diabetes/metabolism research and reviews.

Diagnostic role of plasma ORM2 in differentiating prostate cancer from benign prostatic hyperplasia

Yuanming Fan, G. Ma, Xiaojian Yin, 2022, Journal of Cancer Research and Clinical Oncology.

Expressions of stem cell transcription factors Nanog and Oct4 in renal cell carcinoma tissues and clinical significance

M. Gu, Zicheng Xu, H. Cai, 2016, Artificial cells, nanomedicine, and biotechnology.

A Functional Variant in the MTOR Promoter Modulates Its Expression and Is Associated with Renal Cell Cancer Risk

P. Shao, Pu Li, C. Qin, 2012, PloS one.

Genetic Variations in a PTEN/AKT/mTOR Axis and Prostate Cancer Risk in a Chinese Population

P. Shao, Pu Li, C. Qin, 2012, PloS one.

Clinical characteristics and genetic testing of an atypical familial von Hippel-Lindauzon renal cell carcinoma.

Zicheng Xu, Xiao Li, Feng Qi, 2019, Annals of translational medicine.

Sprouty2 is associated with prognosis and suppresses cell proliferation and invasion in renal cell carcinoma.

P. Shao, Pu Li, C. Qin, 2013, Urology.

A Functional Insertion/Deletion Polymorphism (-94 ins/del ATTG) in the Promoter Region of the NFKB1 Gene Is Related to the Risk of Renal Cell Carcinoma

P. Shao, C. Qin, Q. Cao, 2012, Urologia Internationalis.

Functional Promoter -94 ins/del ATTG Polymorphism in NFKB1 Gene Is Associated with Bladder Cancer Risk in a Chinese Population

C. Yin, X. Yang, Pengchao Li, 2013, PloS one.

TSP-1-1223 A/G Polymorphism as a Potential Predictor of the Recurrence Risk of Bladder Cancer in a Chinese Population

C. Qin, Q. Cao, C. Yin, 2013, International journal of genomics.

Effects of TSP-1-696 C/T polymorphism on bladder cancer susceptibility and clinicopathologic features.

C. Qin, Q. Cao, C. Yin, 2014, Cancer Genetics.

miR‐152 controls migration and invasive potential by targeting TGFα in prostate cancer cell lines

P. Shao, Pu Li, C. Qin, 2013, The Prostate.

LncRNA SNHG1 Facilitates Tumor Proliferation and Represses Apoptosis by Regulating PPARγ Ubiquitination in Bladder Cancer

Haifei Xu, Hongcheng Lu, Weizhang Xu, 2022, Cancers.

The Oncogenic Capacities of Long Noncoding RNA SNHG1 in Bladder Cancer by inducing proliferation and repressing apoptosis via upregulation of microRNA-9-3p-targeted MDM2

Haifei Xu, Weizhang Xu, Yun Hu, 2021 .

RUNX3-mediated circDYRK1A inhibits glutamine metabolism in gastric cancer by up-regulating microRNA-889-3p-dependent FBXO4

H. Cai, Ding Wang, Guangxin Cao, 2022, Journal of translational medicine.

Heterogeneous nuclear ribonucleoprotein U-like 1 and Poly (ADP-ribose) polymerase 1 are downregulated in renal cell carcinoma and connected with the prognosis.

Jing Wu, Wei Zhang, Zicheng Xu, 2013, Cancer biomarkers : section A of Disease markers.

The influence of genetic variants of sorafenib on clinical outcomes and toxic effects in patients with advanced renal cell carcinoma

P. Shao, Pu Li, C. Qin, 2016, Scientific Reports.

A new strategy for the treatment of sorafenib-refractory metastatic renal cell carcinoma in China: combination with intermittent chemotherapy.

Xin Hu, Zicheng Xu, Xiao Li, 2019, Translational andrology and urology.

Neoadjuvant chemotherapy for primary adenocarcinomas of the urinary bladder: a single-site experience

M. Gu, Zicheng Xu, H. Cai, 2015, BMC Urology.